Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent BMYMP. Il ne s'agit pas d'une recommandation d'investissement.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.